What cells does the novel coronavirus attack?
Scientists from the Berlin Institute of Health (BIH), Charité – Universitätsmedizin Berlin...
Read More
Tuberculosis new
New guidelines on caring for ICU patients with COVID-19
International panel does quick turnaround McMaster University Hamilton, ON (April 1, 2020) –...
Read MoreTime to recovery from severe acute malnutrition and its predictors: a multicentre retrospective follow-up study in Amhara region, north-west Ethiopia.
This study aimed to determine the time to recovery from severe acute malnutrition (SAM) and its predictors in selected public health institutions in Amhara Regional State, Ethiopia.An institution-based retrospective follow-up...
Read MoreExtract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross-contamination risk.
Xpert MTB/RIF Ultra (Ultra) detects Mycobacterium tuberculosis and rifampicin resistance. Follow-on drug susceptibility testing (DST) requires additional sputum. Extract from the diamond-shaped chamber of the cartridge (dCE) of...
Read MoreAntibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis.
Mycobacterium tuberculosis remains a global health problem and clinical management is complicated by difficulty in discriminating between latent infection and active disease. While M. tuberculosis-reactive antibody levels are...
Read MoreTuberculosis Transmission or Mortality Among Persons Living with HIV, USA, 2011-2016.
Persons living with HIV are more likely to have tuberculosis (TB) disease attributed to recent transmission (RT) and to die during TB treatment than persons without HIV. We examined factors associated with RT or mortality among...
Read MorePredicting, Preventing, and Managing Treatment-related Complications in Patients With Inflammatory Bowel Diseases.
Risk of complications from specific classes of drugs for inflammatory bowel diseases (IBD) can be kept low by respecting contra-indications. Patients with IBD frequently develop serious infections, due to the disease itself or...
Read MoreChange in TB diagnostic profile after introduction of GeneXpert MTB/RIF assay in National TB Program of Armenia, 2013-2017.
In 2013, the National Tuberculosis (TB) Program of Armenia introduced GeneXpert MTB/RIF (Xpert) assay to address World Health Organization (WHO) target of 80% (2020) of notified new and relapse TB cases to be tested with WHO...
Read MoreQuality of care provided to tuberculosis patients in Armenia: How satisfied are the patients?
Adherence to tuberculosis (TB) treatment as an important determinant for the successful cure of patients can be increased by focusing on patient satisfaction. The objective of this study was to evaluate patient satisfaction with...
Read More